1. Signaling Pathways
  2. GPCR/G Protein
  3. G Protein-coupled Receptor Kinase (GRK)
  4. G Protein-coupled Receptor Kinase (GRK) Agonist

G Protein-coupled Receptor Kinase (GRK) Agonist

G Protein-coupled Receptor Kinase (GRK) Agonists (2):

Cat. No. Product Name Effect Purity
  • HY-125807
    IS20
    Agonist
    IS20 is a Prokineticin receptor 1 (PKR1) agonist. IS20 diminishes Doxorubicin (HY-15142A) mediated apoptosis and production by activating Akt or MAPK pathways. IS20 protects the heart against Doxorubicin-induced cardiovascular toxicity and improves the survival rate and cardiac function in mouse models. IS20 does not alter the cytotoxicity and antitumor activity of acute DOX treatment in breast cancer cells and MDA-MB-231 xenograft mouse models. IS20 can be used for cancers research.
  • HY-12976
    DS-1558
    Agonist
    DS-1558 is an orally active small molecule G protein-coupled receptor 40 agonist. DS-1558 not only increases the glucose-stimulated insulin secretion by glucagon like peptide-1 (GLP-1) but also potentiated the maximum insulinogenic effects of GLP-1 after an intravenous glucose injection in normal Sprague Dawley rats. DS-1558 is promising for research of type 2 diabetes.